论文部分内容阅读
胰酶是一种疗效确切的生化药物。中、美、英、日、苏、欧州药典等均有收载,其复方制剂日益增多,临床应用日益广泛。我国药典及英国药典(1980年版)等都规定有胰酶片的肠溶衣剂型,其理论根据是肠溶衣能保护胰酶通过胃内不利的酸性环境而在碱性小肠液中崩解释放。但据1979年我国卫生部组织各地进行药品临床疗效调查结果,南京地区医务人员反映:胰酶片(肠溶衣剂型)无效,胰酶粉疗效较好。这个调查结果与国外目前所进行的胰酶制剂的试验和新流行的观点是不谋而合的。近年来西方国家多认为肠溶衣胰酶片对大多数病
Pancreatin is a biochemically effective drug. China, the United States, Britain, Japan, the Soviet Union, the European Pharmacopoeia Dengjun contain, the compound preparation is increasing, the clinical application of an increasingly widespread. China’s Pharmacopoeia and the British Pharmacopoeia (1980 edition) and other provisions of pancreatic enteric-coated tablets, the theory is based on the enteric coating can protect pancreatin through the stomach adverse acidic environment in alkaline intestinal fluid collapse and release . However, according to the results of a survey on clinical efficacy of drugs conducted by the Ministry of Health in 1979, medical staff in Nanjing reflected that trypsin tablets (enteric-coated tablets) were ineffective and pancreatin powder had a better therapeutic effect. This survey results coincide with the current trial of trypticase in foreign countries and the new popular opinion. In recent years, many western countries believe that enteric coated pancreatic enzyme tablets for most diseases